Dopamine receptor antagonist structurally related to sulpiride, q.v. Prepn: G. Bulteau et al., DE 2327192; GB 1394563 (1973, 1975 both to Soc. d'Etudes Sci. Ind. de L'Ile-de-France). Crystal structure: C. Houttemane et al., Acta Crystallogr. C39, 585 (1983). Dopamine receptor binding studies: T. Arima et al., Jpn. J. Pharmacol. 41, 419 (1986). Pharmacokinetics: E. Rey et al., Int. J. Clin. Pharmacol. Ther. Toxicol. 20, 62 (1982). Clinical evaluation in neuroleptic-induced dyskinesia: W. Greil et al., Neuropsychobiology 14, 17 (1985); in alcohol withdrawal syndrome: R. Agricola et al., J. Int. Med. Res. 10, 160 (1982); G. K. Shaw et al., Br. J. Psychiatry 150, 164 (1987).
Antidyskinetic.
Antidyskinetic